June 9 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:VRX) VRX.TO :
* U.S. announces $54 million settlement against valeant's VRX.TO salix unit
* Settlement resolves civil fraud claims that salix paid kickbacks to doctors,
to induce them to prescribe its products
* U.S. says salix routinely held sham "speaker programs" where little work got
done, and wined-and-dined doctors who attended
* U.S. says salix admitted and accepted responsibility for some of the alleged
wrongdoing